NR 566 Final
A person with what type of condition should not take echinacea? - Answer-Prolonged use should be
avoided in those who are immunocompromised including HIV, cancer, drug therapy for TB, RA, and SLE
Therapeutic effect of coenzyme Q-10 - Answer-Antioxidant that serves a vital role in cellular energy
production
Structurally similar to vitamin K, not used with warfarin
What is the dietary supplement act of 1994 (DSHEA)? - Answer-Categorizes botanical products (herbal
supplements), vitamins, minerals as dietary (food) supplements rather than drugs. By classifying
products as dietary supplements the DSHEA excepts them from undergoing FDA scrutiny and approval
before marketing. DSHEA does impose restrictions with labeling. All herbal products must be labeled as
dietary supplements.
Ginkgo Biloba adverse effects - Answer-stomach upset, headache, dizziness, vertigo. Some reports of
spontaneous bleeding. Incorrect ingestion can lead to seizures and fatalities (if you eat seeds)
Kava adverse effects - Answer-can cause severe liver injury (ABSOUTELY contraindicated in
hepatotoxicity.
Patient education about administration/consumption about flaxseed - Answer-Flaxseed can reduce
absorption of conventional medications so it should be taken 1 hour before or 2 hours after these drugs
Therapeutic effect of feverfew (dietary supplement) - Answer-Used primarily for migraine prophylaxis,
seasonal allergies, asthma, RA, and psoriasis
, St. Johns wort adverse effects - Answer-insomnia, vivid dreams, restlessness, anxiety, agitation,
irritability, abdominal pain, dry mouth, headache
Ginger root adverse effects - Answer-CNS depression and cardiac dysrhythmias. Excessive doses can
cause GI side effects
Current good manufacturing practices (CGMP) ruling of 2007 - Answer-This ruling ensures that a product
contains what the label proclaims - the package contains ingredients that are listed and does not lack
any.
Set of standards to regulate the manufacturing and labeling of dietary supplements set for by the FDA.
Designed to ensure that dietary supplements be devoid of adulterants, contaminants, and impurities
and tha package labels accurately reflect the identity, purity, quality, and strength of what is inside. In
addition, the label should indicate not only active ingredients but also inactive ingredients. Also
mandates that mfr establish quality-control procedures with the objective of preventing mislabeled,
underfilled, or overfilled formulations, variations in tablet size, color, or potency; and contamination
with drugs, bacteria, pesticides, glass, lead, and other potential contaminants.
Dietary supplement and non-prescription drug consumer protection act of 2006 - Answer-mandates the
reporting of serious averse events for non-prescription drugs and dietary supplements. The following
should be reported: deaths, hospitalizations, life-threatening experiences, persistent or significant
disabilities and birth defects
First line treatment for primary, secondary, or early latent syphilis - Answer-Benzathine penicillin G 2.4
million units IM once
First line treatment for bacterial vaginosis (BV) - Answer-Metronidazole 500 mg PO BID X 7 days
First line treatment for genital herpes (first clinical episode) - Answer-acyclovir 400 mg PO TID x 7-10
days or acyclovir 200 mg PO 5 times a day for 7-10 days or famciclovir 250 mg PO TID/day for 7-10 days
or valacyclovir 1G PO 2 times/day for 7-10 days
A person with what type of condition should not take echinacea? - Answer-Prolonged use should be
avoided in those who are immunocompromised including HIV, cancer, drug therapy for TB, RA, and SLE
Therapeutic effect of coenzyme Q-10 - Answer-Antioxidant that serves a vital role in cellular energy
production
Structurally similar to vitamin K, not used with warfarin
What is the dietary supplement act of 1994 (DSHEA)? - Answer-Categorizes botanical products (herbal
supplements), vitamins, minerals as dietary (food) supplements rather than drugs. By classifying
products as dietary supplements the DSHEA excepts them from undergoing FDA scrutiny and approval
before marketing. DSHEA does impose restrictions with labeling. All herbal products must be labeled as
dietary supplements.
Ginkgo Biloba adverse effects - Answer-stomach upset, headache, dizziness, vertigo. Some reports of
spontaneous bleeding. Incorrect ingestion can lead to seizures and fatalities (if you eat seeds)
Kava adverse effects - Answer-can cause severe liver injury (ABSOUTELY contraindicated in
hepatotoxicity.
Patient education about administration/consumption about flaxseed - Answer-Flaxseed can reduce
absorption of conventional medications so it should be taken 1 hour before or 2 hours after these drugs
Therapeutic effect of feverfew (dietary supplement) - Answer-Used primarily for migraine prophylaxis,
seasonal allergies, asthma, RA, and psoriasis
, St. Johns wort adverse effects - Answer-insomnia, vivid dreams, restlessness, anxiety, agitation,
irritability, abdominal pain, dry mouth, headache
Ginger root adverse effects - Answer-CNS depression and cardiac dysrhythmias. Excessive doses can
cause GI side effects
Current good manufacturing practices (CGMP) ruling of 2007 - Answer-This ruling ensures that a product
contains what the label proclaims - the package contains ingredients that are listed and does not lack
any.
Set of standards to regulate the manufacturing and labeling of dietary supplements set for by the FDA.
Designed to ensure that dietary supplements be devoid of adulterants, contaminants, and impurities
and tha package labels accurately reflect the identity, purity, quality, and strength of what is inside. In
addition, the label should indicate not only active ingredients but also inactive ingredients. Also
mandates that mfr establish quality-control procedures with the objective of preventing mislabeled,
underfilled, or overfilled formulations, variations in tablet size, color, or potency; and contamination
with drugs, bacteria, pesticides, glass, lead, and other potential contaminants.
Dietary supplement and non-prescription drug consumer protection act of 2006 - Answer-mandates the
reporting of serious averse events for non-prescription drugs and dietary supplements. The following
should be reported: deaths, hospitalizations, life-threatening experiences, persistent or significant
disabilities and birth defects
First line treatment for primary, secondary, or early latent syphilis - Answer-Benzathine penicillin G 2.4
million units IM once
First line treatment for bacterial vaginosis (BV) - Answer-Metronidazole 500 mg PO BID X 7 days
First line treatment for genital herpes (first clinical episode) - Answer-acyclovir 400 mg PO TID x 7-10
days or acyclovir 200 mg PO 5 times a day for 7-10 days or famciclovir 250 mg PO TID/day for 7-10 days
or valacyclovir 1G PO 2 times/day for 7-10 days
